US 12351614
CLEC9A-based chimeric protein complexes
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 12351614 (CLEC9A-based chimeric protein complexes) held by Orionis Biosciences, Inc expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P35/00